Can a Durable Disease-Free Survival be Achieved With Surgical Resection in Patients With Pathological Node Positive Renal Cell Carcinoma?
- 31 October 2011
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 186 (4), 1236-1241
- https://doi.org/10.1016/j.juro.2011.05.051
Abstract
Patients with isolated regional nodal metastases from renal cell carcinoma are a distinct cohort for which resection of involved lymph nodes may be therapeutic. We assessed the outcomes of patients treated at our institution with pathological node positive renal cell carcinoma without concomitant metastatic disease (TanyN+M0). A total of 2,521 patients with nonmetastatic renal cell carcinoma (TanyNanyM0) of any histological subtype treated with nephrectomy were identified between 1995 and 2009. Pathological regional node positive disease in the absence of clinically detectable metastases (TanyN1-2M0) was present in 68 patients (2.7%) and these patients formed our study cohort. Patients were assessed for timing and location of recurrence, disease specific survival and overall survival. Multivariate Cox regression analysis was performed to define factors predictive of recurrence and overall survival. Of the 68 patients with TanyN1-2M0 renal cell carcinoma 22.1% were free of disease at a median followup of 43.5 months. In those patients experiencing recurrence, disease was detected within the first 4 months after surgery in 51% and was most commonly detected at multiple organ sites. The Kaplan-Meier estimated 5-year overall survival and disease specific survival was 37% and 39%, respectively. Predictors of a favorable outcome included an Eastern Cooperative Oncology Group performance status of 0, single node involvement, absence of sarcomatoid features and papillary histology. Nephrectomy with lymph node dissection can provide a durable disease-free survival in a proportion of patients with regionally advanced renal cell carcinoma and limited lymph node metastases.Keywords
This publication has 18 references indexed in Scilit:
- The role of lymphadenectomy in renal cell carcinomaCurrent Opinion in Urology, 2009
- Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881European Urology, 2009
- The Role of Lymph Node Dissection in Renal Cell Carcinoma: The Pendulum Swings BackThe Cancer Journal, 2008
- Patients with renal cell carcinoma nodal metastases can be accurately identified: External validation of a new nomogramInternational Journal of Cancer, 2007
- Renal Cell Carcinoma With Nodal Metastases in the Absence of Distant Metastatic Disease (Clinical Stage TxN1-2M0): The Impact of Aggressive Surgical Resection on Patient OutcomeJournal of Urology, 2006
- Reassessing the Current TNM Lymph Node Staging for Renal Cell CarcinomaEuropean Urology, 2006
- A PROTOCOL FOR PERFORMING EXTENDED LYMPH NODE DISSECTION USING PRIMARY TUMOR PATHOLOGICAL FEATURES FOR PATIENTS TREATED WITH RADICAL NEPHRECTOMY FOR CLEAR CELL RENAL CELL CARCINOMAJournal of Urology, 2004
- Renal Cell Carcinoma With Retroperitoneal Lymph Nodes: Role of Lymph Node DissectionJournal of Urology, 2003
- Enlargement of Regional Lymph Nodes in Renal Cell Carcinoma is Often not Due to MetastasesJournal of Urology, 1990
- The Results of Radical Nephrectomy for Renal Cell CarcinomaJournal of Urology, 1969